Atorvastatin Calcium
Product Images NDC 68071-2452

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 01)

Image-01 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 01)
Chemical structure of Atorvastatin Calcium, showing two molecules complexed with calcium ions and three water molecules (Ca2+·3H2O). The structure includes multiple aromatic rings and hydroxyl groups, characteristic of atorvastatin's molecular composition.*
FDA Label Image

Image-02 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 02)

Image-02 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 02)
A line graph showing cumulative incidence over time (years) comparing Atorvastatin and a placebo. The graph includes hazard ratio data (HR=0.64) with confidence intervals and a p-value (p=0.0005). The y-axis represents cumulative incidence percentage and the x-axis shows time in years up to 3.5 years.*
FDA Label Image

Image-03 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 03)

Image-03 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 03)
A line chart showing cumulative hazard percentages over a 4-year follow-up period comparing Atorvastatin and placebo groups. The x-axis represents time in years, while the y-axis shows cumulative hazard percentage. Atorvastatin shows a lower cumulative hazard than placebo, with a hazard ratio (HR) of 0.63 and a p-value of 0.001.*
FDA Label Image

Image-05 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 04)

Image-05 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 04)
A line graph comparing the percentage of subjects experiencing a first major cardiovascular endpoint over time (years) for Atorvastatin 10 mg and Atorvastatin 80 mg. The graph shows a lower event rate for the 80 mg dose, with a hazard ratio (HR) of 0.78 and a p-value of 0.0002 indicating statistical significance.*
FDA Label Image

Pdp (68071 2452 9)

Pdp (68071 2452 9)
Label for Atorvastatin Calcium 20 mg tablets from NuCare Pharmaceuticals, Inc. The bottle contains 90 tablets. The label includes NDC 68071-2452-9, manufacturer Lupin Limited, and cautions to keep out of reach of children and store at controlled temperature 68-77°F. It is marked Rx Only with instructions to see manufacturer's label for full ingredients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.